|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.00 USD | -2.20% |
|
-3.31% | -16.32% |
| 05-16 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
| 05-16 | Top Midday Gainers | MT |
| Capitalization | 10.55B 9.15B 8.59B 7.81B 14.34B 911B 16.22B 100B 39.14B 416B 39.57B 38.74B 1,530B | P/E ratio 2025 * |
16.3x | P/E ratio 2026 * | 12.9x |
|---|---|---|---|---|---|
| Enterprise value | 8.82B 7.65B 7.18B 6.53B 11.99B 761B 13.56B 83.87B 32.73B 348B 33.08B 32.39B 1,280B | EV / Sales 2025 * |
2.81x | EV / Sales 2026 * | 2.32x |
| Free-Float |
99.12% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: BioMarin Pharmaceutical Inc.
More recommendations
More press releases
More news
| 1 day | -2.20% | ||
| 1 week | -3.31% | ||
| Current month | -5.29% | ||
| 1 month | -7.20% | ||
| 3 months | -23.13% | ||
| 6 months | -16.08% | ||
| Current year | -16.32% |
| 1 week | 54.89 |  | 58.17 |
| 1 month | 54.89 | | 60.48 |
| Current year | 52.93 | | 73.51 |
| 1 year | 52.93 | | 94.85 |
| 3 years | 52.93 | | 117.77 |
| 5 years | 52.93 | | 131.94 |
| 10 years | 52.93 | | 151.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Hardy
CEO | Chief Executive Officer | 56 | 30/11/2023 |
Brian Mueller
DFI | Director of Finance/CFO | 51 | 28/01/2020 |
Gregory Friberg
CTO | Chief Tech/Sci/R&D Officer | 51 | 29/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Randy Meier
CHM | Chairman | 65 | 30/11/2023 |
Willard Dere
BRD | Director/Board Member | 71 | 17/07/2016 |
Robert Hombach
BRD | Director/Board Member | 59 | 28/09/2017 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 3.45% | 1 M€ | -.--% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.20% | -3.31% | -35.31% | -23.79% | 10.55B | ||
| +0.59% | -1.38% | -16.63% | -6.92% | 75.35B | ||
| -0.39% | +1.50% | +37.72% | +28.48% | 52.44B | ||
| -2.35% | -1.46% | +15.27% | +100.90% | 34.64B | ||
| -3.42% | -5.66% | -44.11% | -33.92% | 18.54B | ||
| +0.39% | -1.71% | +104.07% | +203.91% | 16.22B | ||
| +5.19% | +10.04% | +53.02% | +952.11% | 15.5B | ||
| -0.04% | -.--% | +94.58% | +133.27% | 14.02B | ||
| -3.38% | -1.55% | +9.76% | +1.13% | 13.32B | ||
| -2.20% | -12.17% | -4.63% | -32.48% | 11.29B | ||
| Average | -0.75% | -2.07% | +21.37% | +132.27% | 26.19B | |
| Weighted average by Cap. | -0.46% | -2.19% | +15.19% | +88.46% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 3.14B 2.73B 2.56B 2.33B 4.27B 271B 4.83B 29.87B 11.66B 124B 11.78B 11.54B 456B | 3.45B 3B 2.81B 2.56B 4.69B 298B 5.31B 32.83B 12.81B 136B 12.95B 12.68B 501B |
| Net income | 666M 578M 543M 494M 906M 57.55B 1.02B 6.34B 2.47B 26.29B 2.5B 2.45B 96.71B | 848M 736M 691M 629M 1.15B 73.26B 1.3B 8.07B 3.15B 33.47B 3.18B 3.12B 123B |
| Net Debt | -1.73B -1.5B -1.41B -1.28B -2.35B -149B -2.66B -16.44B -6.42B -68.21B -6.49B -6.35B -251B | -2.53B -2.2B -2.06B -1.87B -3.44B -218B -3.89B -24.06B -9.39B -99.81B -9.49B -9.29B -367B |
More financial data
* Estimated data
Employees
3,040
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/06/25 | 55.00 $ | -2.20% | 2,205,841 |
| 16/06/25 | 56.24 $ | +0.04% | 1,574,673 |
| 13/06/25 | 56.22 $ | -1.85% | 1,623,371 |
| 12/06/25 | 57.28 $ | +0.21% | 1,428,427 |
| 11/06/25 | 57.16 $ | -0.56% | 1,849,152 |
Delayed Quote Nasdaq, June 17, 2025 at 09:00 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
55.00USD
Average target price
95.91USD
Spread / Average Target
+74.38%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BMRN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition